Physical Activity and Sports for People With Visual Impairments
NCT06318000
Blindness, Eye Diseases
Warsaw, Poland
View Trial DetailsNCT Number: NCT00964613
Cataract is a leading cause of Global blindness. After cataract surgery nearly half of the people become blind due to posterior capsular opacification. The only solution for this problem is LASER capsulotomy. Laser machine is not available in remote areas especially in underdeveloped countries. The solution of this problem is surgical capsulotomy which can be performed any where.
Looking for future studies?
Notify Me1 year–95 year
All sexes
Observational
posterior capsular opacification is treated by YAG laser capsulotomy. this require sophisticated technology ans specific environment which is not possible in underdeveloped countries. we describe a method in which posterior capsular opacification could be managed by using only a 27 Gauge needle through pars plana. opacified posterior capsule is under tension that is why a small puncture results in a large central opening
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Dow University of Health Sciences
Other
Acronym: Capsulotomy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06318000
Blindness, Eye Diseases
Warsaw, Poland
View Trial DetailsNCT02643238
Blindness, Eye Diseases
Akron, Ohio, United States
View Trial DetailsNCT05608811
Blindness, Blindness Congenital
Ankara, Turkey (Türkiye)
View Trial DetailsNCT04936100
Blindness, Eye Diseases
Tehran, Iran
View Trial Details